733
edits
Brugada Syndrome: Difference between revisions
→Treatment
| Line 76: | Line 76: | ||
*Fever may also provoke type 1 ECG and VF. Patients with fever are advised to go to the hospital to make an ECG. When ECG changes are present, monitoring is warranted and antipyretics are needed. | *Fever may also provoke type 1 ECG and VF. Patients with fever are advised to go to the hospital to make an ECG. When ECG changes are present, monitoring is warranted and antipyretics are needed. | ||
=== | ===Medication/Other therapies:=== | ||
*[[ICD]] implantation is first line therapy in Brugada patients with a previous cardiac arrest, [[ventricular tachycardia]] or cardiac [[syncope]]. ICD implantation in asymptomatic patients is not advised and needs careful judgement regarding the low annual rate of arrhythmic events and high incidence rate of complications (7.5 per 100 patient-years). | *[[ICD]] implantation is first line therapy in Brugada patients with a previous cardiac arrest, [[ventricular tachycardia]] or cardiac [[syncope]]. ICD implantation in asymptomatic patients is not advised and needs careful judgement regarding the low annual rate of arrhythmic events and high incidence rate of complications (7.5 per 100 patient-years). | ||
*In Brugada patients with recurrent VF events or ICD shocks, isoproterenol or quinidine are known to be effective for VF suppression in both children and adults. | *In Brugada patients with recurrent VF events or ICD shocks, isoproterenol or quinidine are known to be effective for VF suppression in both children and adults. | ||